Jillian Thomsen

Track

Insider profile

Currently holds a position at Nektar Therapeutics

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
20 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Finance, Chief Accounting Officer Nektar Therapeutics Feb. 1, 2010 -
Jillian Thomsen's trades of Nektar Therapeutics's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
80.13
Quantity 41,949 -13.9%
Value US$2,073,978
Transaction date
Sale
Price
270.50
Quantity 67,067 -29.6%
Value US$4,119,655
Transaction date
Sale
Price
194.68
Quantity 41,065 -39.1%
Value US$4,897,634
Transaction date
Sale
Price
18.30
Quantity 13,391 -8.1%
Value US$245,055
Transaction date
Sale
Price
22.37
Quantity 11,705 -6.6%
Value US$261,841
Transaction date
Planned sale
Price
18.62
Quantity 75,000 -29.8%
Value US$1,396,500
Transaction date
Sale
Price
16.93
Quantity 11,976 -7.0%
Value US$202,754
Transaction date
Planned sale
Price
22.78
Quantity 37,500 -17.6%
Value US$854,250
Transaction date
Planned sale
Price
42.16
Quantity 16,119 -8.7%
Value US$679,577
Transaction date
Sale
Price
38.25
Quantity 4,016 -2.5%
Value US$153,612
Transaction date
Sale
Price
82.94
Quantity 2,545 -3.6%
Value US$211,082
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-17 2023-02-16
S Sale
41,949 -13.9%
80.13
US$2,073,978 		41,949 -13.9% 80.13 US$2,073,978
2022-11-18 2022-11-16
S Sale
67,067 -29.6%
270.50
US$4,119,655 		67,067 -29.6% 270.50 US$4,119,655
2022-08-17 2022-08-16
S Sale
41,065 -39.1%
194.68
US$4,897,634 		41,065 -39.1% 194.68 US$4,897,634
2022-05-17 2022-05-16
S Sale
5,841 -3.3%
3.95
US$23,072 		5,841 -3.3% 3.95 US$23,072
2022-02-18 2022-02-16
S Sale
2,363 -1.4%
10.95
US$25,875 		2,363 -1.4% 10.95 US$25,875
2021-11-17 2021-11-16
S Sale
6,741 -4.4%
13.16
US$88,712 		6,741 -4.4% 13.16 US$88,712
2021-05-19 2021-05-17
S Sale
13,391 -8.1%
18.30
US$245,055 		13,391 -8.1% 18.30 US$245,055
2021-02-18 2021-02-16
S Sale
11,705 -6.6%
22.37
US$261,841 		11,705 -6.6% 22.37 US$261,841
2021-01-29 2021-01-28
PlS Planned sale
75,000 -29.8%
18.62
US$1,396,500 		75,000 -29.8% 18.62 US$1,396,500
2020-11-18 2020-11-16
S Sale
11,976 -7.0%
16.93
US$202,754 		11,976 -7.0% 16.93 US$202,754
2020-08-19 2020-08-17
S Sale
1,367 -0.8%
19.67
US$26,889 		1,367 -0.8% 19.67 US$26,889
2020-05-20 2020-05-18
S Sale
1,367 -0.8%
22.51
US$30,771 		1,367 -0.8% 22.51 US$30,771
2020-02-20 2020-02-18
S Sale
1,394 -0.8%
22.35
US$31,156 		1,394 -0.8% 22.35 US$31,156
2020-02-07 2020-02-06
PlS Planned sale
37,500 -17.6%
22.78
US$854,250 		37,500 -17.6% 22.78 US$854,250
2019-11-20 2019-11-18
S Sale
2,713 -1.7%
17.97
US$48,753 		2,713 -1.7% 17.97 US$48,753
2019-08-19 2019-08-16
S Sale
1,809 -1.1%
18.15
US$32,833 		1,809 -1.1% 18.15 US$32,833
2019-05-17 2019-05-16
S Sale
1,928 -1.2%
31.37
US$60,481 		1,928 -1.2% 31.37 US$60,481
2019-02-21 2019-02-19
S Sale
1,808 -1.1%
42.39
US$76,641 		1,808 -1.1% 42.39 US$76,641
2019-02-06 2019-02-04
PlS Planned sale
16,119 -8.7%
42.16
US$679,577 		16,119 -8.7% 42.16 US$679,577
2018-11-19 2018-11-16
S Sale
4,016 -2.5%
38.25
US$153,612 		4,016 -2.5% 38.25 US$153,612
2018-02-20 2018-02-16
S Sale
2,545 -3.6%
82.94
US$211,082 		2,545 -3.6% 82.94 US$211,082
2017-08-18 2017-08-16
S Sale
2,648 -5.0%
19.32
US$51,159 		2,648 -5.0% 19.32 US$51,159
2017-05-18 2017-05-16
S Sale
2,651 -4.8%
19.55
US$51,827 		2,651 -4.8% 19.55 US$51,827